PAETON MOYLE: Open Payments
NPI 1225595911 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 27 payments from 12 companies in 2025. Trend: 2023 $1,107 · 2024 $603 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $164 |
| Janssen Biotech, Inc. | 4 | $79 |
| GENZYME CORPORATION | 2 | $49 |
| Lilly USA, LLC | 3 | $48 |
| UCB, Inc. | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $34 |
| KYOWA KIRIN, INC. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: BOTOX, TREMFYA, DUPIXENT, EBGLYSS, SKYRIZI, Bimzelx, NEMLUVIO, POTELIGEO.
Industry payments across SD — which companies pay providers there.
